Fixed-combination products offer option for greater IOP-lowering
Fixed-combination therapies may have a role in glaucoma management when monotherapy reduces IOP but not sufficiently to reach the target level, said Luca Rossetti, MD, professor of ophthalmology, University of Milan, Italy.